Publications

2012

Krairojananan P, Sattabongkot J, Chavalitshewinkoon-Petmitr P. 2012. Effect of peritrophic matrix C-type lectin (AdPMCTL) on blood-meal size in Anopheles dirus. Southeast Asian J Trop Med Public Health. Sep;43(5):1134-45.

Xangsayarath P, Kaewthamasorn M, Yahata K, Nakazawa S, Sattabongkot J, Udomsangpetch R, Kaneko O. 2012. Positive Diversifying Selection on the Plasmodium falciparumsurf Gene in Thailand. Trop Med Health. 40(3):79-89.

Alexandre JS, Xangsayarath P, Kaewthamasorn M, Yahata K, Sattabongkot J, Udomsangpetch R, Kaneko O. 2012. Stable Allele Frequency Distribution of the Plasmodium falciparum clag Genes Encoding Components of the High Molecular Weight Rhoptry Protein Complex. Trop Med Health. 40(3):71-7.

Kennedy M, Fishbaugher ME, Vaughan AM, Patrapuvich R, Boonhok R, Yimamnuaychok N, Rezakhani N, Metzger P, Ponpuak M, Sattabongkot J, Kappe SH, Hume JC, Lindner SE. 2012. A rapid and scalable density gradient purification method for Plasmodium sporozoites. Malar J. 11(1):421.

Lu F, Wang B, Cao J, Sattabongkot J, Zhou H, Zhu G, Kim K, Gao Q, Han ET. 2012. Prevalence of Drug Resistance-Associated Gene Mutations in Plasmodium vivax in Central China. Korean J Parasitol. 50(4):379-84.

Wang B, Lu F, Cheng Y, Li J, Ito D, Sattabongkot J, Tsuboi T, Han ET. 2012.Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax. Parasitol Res. 2012 Oct 25.

Eksi S, Morahan BJ, Haile Y, Furuya T, Jiang H, Ali O, Xu H, Kiattibutr K, Suri A,Czesny B, Adeyemo A, Myers TG, Sattabongkot J, Su XZ, Williamson KC. 2012. Plasmodium falciparum Gametocyte Development 1 (Pfgdv1) and Gametocytogenesis Early Gene Identification and Commitment to Sexual Development. PLoS Pathog. Oct;8(10).

Jangpatarapongsa K, Xia H, Fang Q, Hu K, Yuan Y, Peng M, Gao Q, Sattabongkot J, Cui L, Li B,Udomsangpetch R. 2012. Immunity to Malaria in Plasmodium vivax Infection: A Study in Central China. PLoS One. 2012;7(9).

Parker D, Lerdprom R, Srisatjarak W, Yan G, Sattabongkot J, Wood J, Sirichaisinthop J, Cui L. 2012. Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010. Malar J. 11(1): 290.

Deye GA, Gettayacamin M, Hansukjariya P, Im-Erbsin R, Sattabongkot J, Rothstein Y, Macareo L, Fracisco S, Bennett K, Magill AJ, Ohrt C. 2012. Use of a Rhesus Plasmodium cynomolgi Model to Screen for Anti-Hypnozoite Activity of Pharmaceutical Substances. Am J Trop Med Hyg. 86(6):931-5.

Sriwichai P, Rongsiryam Y, Jariyapan N, Sattabongkot J, Apiwathnasorn C, Nacapunchai D, Paskewitz S. 2012. Cloning of a trypsin-like serine protease and expression patterns during Plasmodium falciparum invasion in the mosquito, Anopheles dirus (Peyton and Harrison). Arch Insect Biochem Physiol. 2012 May 24.

Lurchachaiwong W, Monkanna T, Leepitakrat S, Ponlawat A, Sattabongkot J, Schuster AL, McCardle PW, Richards AL. 2012. Variable clinical responses of a scrub typhus outbred mouse model to feeding byOrientia tsutsugamushi infected mites. Exp Appl Acarol.

Tonwong N, Sattabongkot J, Tsuboi T, Iriko H, Takeo S, Sirichaisinthop J, Udomsangpetch R. 2012. Natural Infection of Plasmodium falciparum Induces Inhibitory Antibodies against Gametocyte Development in Human Hosts. Jpn J Infect Dis. 2012 Mar;65(2):152-6.

Lumsden JM, Nurmukhambetova S, Klein JH, Sattabongkot J, Bennett JW, Reed SG, Ockenhouse CF, Howard RF, Polhemus ME, Yadava A. 2012. Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant vaccine candidate in combination with second-generation adjuvants in mice. Vaccine.

Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, Ha KS, Cao J, Torii M, Sattabongkot J, Tsuboi T, Han ET. 2012. Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to protein the merozoite rhoptry. Parasitol Int.

Kaewthamasorn M, Yahata K, Alexandre JS, Xangsayarath P, Nakazawa S, Torii M, Sattabongkot J, Udomsangpetch R, Kaneko O. 2012. Stable allele frequency distribution of the polymorphic region of SURFIN(4.2) in Plasmodium falciparum isolates from Thailand. Parasitol Int. 2012 Jun;61(2):317-23.

Sakamoto H, Takeo S, Maier AG, Sattabongkot J, Cowman AF, Tsuboi T. 2012. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Vaccine. 30(11):1972-80.

Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T. 2012. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate. Vaccine.;30(10):1807-12.

Lapcharoen P, Komalamisra N, Rongsriyam Y, Wangsuphachart V, Dekumyoy P, Prachumsri J, Kajla MK, Paskewitz SM, 2012. Investigations on the role of a lysozyme from the malaria vector Anopheles dirus during malaria parasite development. Dev Comp Immunol 36: 104-11.

Chansamut N, Buates S, Takhampunya R, Udomsangpetch R, Bantuchai S, Sattabongkot J. 2012. Correlation of Pfg377 ortholog gene expression of Plasmodium vivax and mosquito infection. Trop Med Int Health.

Wang B, Lu F, Cheng Y, Li J, Ito D, Sattabongkot J, Tsuboi T, Han ET. 2012 Oct 25. Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax. Parasitol Res.

Eksi S, Morahan BJ, Haile Y, Furuya T, Jiang H, Ali O, Xu H, Kiattibutr K, Suri A,Czesny B, Adeyemo A, Myers TG, Sattabongkot J, Su XZ, Williamson KC. 2012. Plasmodium falciparum Gametocyte Development 1 (Pfgdv1) and Gametocytogenesis Early Gene Identification and Commitment to Sexual Development. PLoS Pathog. Oct;8(10).

Jangpatarapongsa K, Xia H, Fang Q, Hu K, Yuan Y, Peng M, Gao Q, Sattabongkot J, Cui L, Li B,Udomsangpetch R. 2012. Immunity to Malaria in Plasmodium vivax Infection: A Study in Central China. PLoS One. 7(9).

Parker D, Lerdprom R, Srisatjarak W, Yan G, Sattabongkot J, Wood J, Sirichaisinthop J, Cui L. 2012. Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010. Malar J. 11(1): 290.

Deye GA, Gettayacamin M, Hansukjariya P, Im-Erbsin R, Sattabongkot J, Rothstein Y, Macareo L, Fracisco S, Bennett K, Magill AJ, 2012. Ohrt C. Use of a Rhesus Plasmodium cynomolgi Model to Screen for Anti-Hypnozoite Activity of Pharmaceutical Substances. Am J Trop Med Hyg. 86(6):931-5.

Sriwichai P, Rongsiryam Y, Jariyapan N, Sattabongkot J, Apiwathnasorn C, Nacapunchai D, Paskewitz S. 2012. Cloning of a trypsin-like serine protease and expression patterns during Plasmodium falciparum invasion in the mosquito, Anopheles dirus (Peyton and Harrison). Arch Insect Biochem Physiol. 2012 May 24.

Lurchachaiwong W, Monkanna T, Leepitakrat S, Ponlawat A, Sattabongkot J, Schuster AL, McCardle PW, Richards AL. 2012. Variable clinical responses of a scrub typhus outbred mouse model to feeding byOrientia tsutsugamushi infected mites. Exp Appl Acarol.

Takahashi N, Tanabe K, Tsukahara T, Dzodzomenyo M, Dysoley L, Khamlome B, Sattabongkot J,Nakamura M, Sakurai M, Kobayashi J, Kaneko A, Endo H, Hombhanje F, Tsuboi T, Mita T. 2012. Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt.11(1):92.

Tonwong N, Sattabongkot J, Tsuboi T, Iriko H, Takeo S, Sirichaisinthop J, Udomsangpetch R. 2012. Natural Infection of Plasmodium falciparum Induces Inhibitory Antibodies against Gametocyte Development in Human Hosts. Jpn J Infect Dis 2012 Mar.;65(2):152-6.

Lumsden JM, Nurmukhambetova S, Klein JH, Sattabongkot J, Bennett JW, Reed SG, Ockenhouse CF, Howard RF, Polhemus ME, Yadava A. 2012. Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant vaccine candidate in combination with second-generation adjuvants in mice. Vaccine.

Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, Ha KS, Cao J, Torii M, Sattabongkot J, Tsuboi T, Han ET. 2012. Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to protein the merozoite rhoptry. Parasitol Int.

Kaewthamasorn M, Yahata K, Alexandre JS, Xangsayarath P, Nakazawa S, Torii M, Sattabongkot J, Udomsangpetch R, Kaneko O. 2012. Stable allele frequency distribution of the polymorphic region of SURFIN(4.2) in Plasmodium falciparum isolates from Thailand. Parasitol Int 2012 Jun.;61(2):317-23.

Sakamoto H, Takeo S, Maier AG, Sattabongkot J, Cowman AF, Tsuboi T. 2012. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Vaccine. 30(11):1972-80.

Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T. 2012. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate. Vaccine.2012;30(10):1807-12.

Lapcharoen P, Komalamisra N, Rongsriyam Y, Wangsuphachart V, Dekumyoy P, Prachumsri J, Kajla MK, Paskewitz SM. 2012. Investigations on the role of a lysozyme from the malaria vector Anopheles dirus during malaria parasite development. Dev Comp Immunol 36: 104-11.

Chansamut N, Buates S, Takhampunya R, Udomsangpetch R, Bantuchai S, Sattabongkot J. 2012. Correlation of Pfg377 ortholog gene expression of Plasmodium vivax and mosquito infection. Trop Med Int Health.

Sakamoto H, Takeo S, Maier AG, Sattabongkot J, Cowman AF, Tsuboi T. 2012. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Vaccine. 2012 Jan 13.

Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T. 2012. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate. Vaccine. 2012 Jan 10.

Lapcharoen P, Komalamisra N, Rongsriyam Y, Wangsuphachart V, Dekumyoy P, Prachumsri J, Kajla MK, Paskewitz SM. 2012. Investigations on the role of a lysozyme from the malaria vector Anopheles dirus during malaria parasite development. Dev Comp Immunol 2012 Jan.;36(1):104-11.

2011

Kaewthamasorn M, Yahata K, Alexandre JS, Xangsayarath P, Nakazawa S, Torii M, Sattabongkot J, Udomsangpetch R, Kaneko O. 2011. Stable allele frequency distribution of the polymorphic region of SURFIN(4.2) in Plasmodium falciparum isolates from Thailand. Parasitol Int. 2011 Dec 27.

Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, Groessl T, Kato N, Lee MC, McNamara CW, Fidock DA, Nagle A, Nam TG, Richmond W, Roland J, Rottmann M, Zhou B, Froissard P, Glynne RJ, Mazier D, Sattabongkot J, Schultz PG, Tuntland T, Walker JR, Zhou Y, Chatterjee A, Diagana TT, Winzeler EA. 2011. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science 2011 Dec 9;334(6061):1372-7.

Sirichaisinthop J, Buates S, Watanabe R, Han ET, Suktawonjaroenpon W, Krasaesub S, Takeo S, Tsuboi T, Sattabongkot J. 2011. Evaluation of loop-mediated isothermal amplification (LAMP) for malaria diagnosis in a field setting. Am J Trop Med Hyg 2011 Oct.;85(4):594-6.

Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, Zhou H, Long CA, Sattabongkot J, Thompson J, Wilson DW, Beeson JG, Healer J, Crabb BS, Cowman AF, Torii M, Tsuboi T. 2011. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. Infect Immun 2011 Nov;79(11):4523-32.

Lu F, Gao Q, Chotivanich K, Xia H, Cao J, Udomsangpetch R, Cui L, Sattabongkot J. 2011. In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China. Am J Trop Med Hyg 2011 Aug;85(2):197-201.

Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Ikehara A, Tachibana M, Torii M, Matsuzaki G, Arakawa T. 2011. Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development. Infect Immun 2011 Oct;79(10):4260-75.

Dow GS, Gettayacamin M, Hansukjariya P, Imerbsin R, Komcharoen S, Sattabongkot J, Kyle D, Milhous W, Cozens S, Kenworthy D, Miller A, Veazey J, Ohrt C. 2011. Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta). Malar J 2011 Jul 29;10:212.

Bonizzoni M, Bourjea J, Chen B, Crain BJ, Cui L, Fiorentino V, Hartmann S, Hendricks S, Ketmaier V, Ma X, Muths D, Pavesi L, Pfautsch S, Rieger MA, Santonastaso T, Sattabongkot J, Taron CH, Taron DJ, Tiedemann R, Yan G, Zheng B, Zhong D. 2011. Permanent Genetic Resources added to Molecular Ecology Resources Database 1 April 2011-31 May 2011. Molecular Ecology Resources Primer Development Consortium. Mol Ecol Resour 2011 Sep;11(5):935-6.

Tachibana M, Wu Y, Iriko H, Muratova O, MacDonald NJ, Sattabongkot J, Takeo S, Otsuki H, Torii M, Tsuboi T. 2011. N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity. Clin Vaccine Immunol 2011 Aug;18(8):1343-50.

Lumsden JM, Pichyangkul S, Srichairatanakul U, Yongvanitchit K, Limsalakpetch A, Nurmukhambetova S, Klein J, Bertholet S, Vedvick TS, Reed SG, Sattabongkot J, Bennett JW, Polhemus ME, Ockenhouse CF, Howard RF, Yadava A. 2011. Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion. Infect Immun 2011 Sep;79(9):3492-500.

Roobsoong W, Roytrakul S, Sattabongkot J, Li J, Udomsangpetch R, Cui L. 2011. Determination of the Plasmodium vivax schizont stage proteome. J Proteomics 2011 Aug 24;74(9):1701-10.

Cui L, Yan G, Sattabongkot J, Chen B, Cao Y, Fan Q, Parker D, Sirichaisinthop J, Su XZ, Yang H, Yang Z, Wang B, Zhou G. 2011. Challenges and prospects for malaria elimination in the Greater Mekong Subregion. Acta Trop. 2011 Apr 14.

Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M, Zeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M, Sattabongkot J, Cao YM, Horii T, Torii M, Tsuboi T. 2011. Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax. Vaccine 2011 Jun 10;29(26):4308-15.

Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, Fan Q, Fang Q, Jongwutiwes S, Parker D, Sirichaisinthop J, Kyaw MP, Su XZ, Yang H, Yang Z, Wang B, Xu J, Zheng B, Zhong D, Zhou G. 2011. Malaria in the Greater Mekong Subregion: Heterogeneity and complexity. Acta Trop. 2011 Mar 5.

Miyata T, Harakuni T, Sugawa H, Sattabongkot J, Kato A, Tachibana M, Torii M, Tsuboi T, Arakawa T. 2011. Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine. Vaccine 2011 Mar 24;29(15):2720-6.

Wang Y, Kaneko O, Sattabongkot J, Chen JH, Lu F, Chai JY, Takeo S, Tsuboi T, Ayala FJ, Chen Y, Lim CS, Han ET. 2011. 2011. Genetic polymorphism of Plasmodium vivax msp1p, a paralog of merozoite surface protein 1, from worldwide isolates. Am J Trop Med Hyg 2011 Feb;84(2):292-7.

Lee WJ, Kim HH, Hwang SM, Park MY, Kim NR, Cho SH, In TS, Kim JY, Sattabongkot J, Sohn Y, Kim H, Lee JK, Lee HW. 2011. Detection of an antibody against Plasmodium vivax in residents of Gimpo-si, South Korea, using an indirect fluorescent antibody test. Malar J 2011 Jan 31;10:19.